SK
Sanjay Khandu Totare
About Sanjay Khandu Totare
Data last updated:
Sanjay Khandu Totare has 18 years in corporate governance. Holds Director role. Currently with 2 companies, including Perivinc Pharmaceuticals Private Limited and Yashica Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹22.02 Cr; the largest is Yashica Pharmaceuticals Private Limited at ₹17.20 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Nov 2007 | 2007 | ₹17.20 Cr (FY 2025) | Active | |
| Director | 06 Mar 2018 | 2010 | ₹4.83 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Khandu Totare
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Khandu Totare
Sanjay Khandu Totare has 18 years in corporate governance. Holds Director role. Currently with 2 companies, including Perivinc Pharmaceuticals Private Limited and Yashica Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹22.02 Cr; the largest is Yashica Pharmaceuticals Private Limited at ₹17.20 Cr (FY 2025).
Sanjay Khandu Totare is associated with 2 companies as Director, including Yashica Pharmaceuticals Private Limited (₹17.20 Cr), Perivinc Pharmaceuticals Private Limited (₹4.83 Cr).
Sanjay Khandu Totare has expertise in General Business.
Sanjay Khandu Totare has 18 years in corporate governance.
By reported revenue, the largest current company of Sanjay Khandu Totare is Yashica Pharmaceuticals Private Limited, with revenue of ₹17.20 Cr (FY 2025).
The 2 current companies of Sanjay Khandu Totare that report revenue have a combined latest revenue of ₹22.02 Cr.
Sanjay Khandu Totare currently holds positions at 2 companies: Yashica Pharmaceuticals Private Limited (₹17.20 Cr), Perivinc Pharmaceuticals Private Limited (₹4.83 Cr).